Dheilly, E.; Majocchi, S.; Moine, V.; Didelot, G.; Broyer, L.; Calloud, S.; Malinge, P.; Chatel, L.; Ferlin, W.G.; Kosco-Vilbois, M.H.;
et al. Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity. Antibodies 2018, 7, 3.
https://doi.org/10.3390/antib7010003
AMA Style
Dheilly E, Majocchi S, Moine V, Didelot G, Broyer L, Calloud S, Malinge P, Chatel L, Ferlin WG, Kosco-Vilbois MH,
et al. Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity. Antibodies. 2018; 7(1):3.
https://doi.org/10.3390/antib7010003
Chicago/Turabian Style
Dheilly, Elie, Stefano Majocchi, Valéry Moine, Gérard Didelot, Lucile Broyer, Sébastien Calloud, Pauline Malinge, Laurence Chatel, Walter G. Ferlin, Marie H. Kosco-Vilbois,
and et al. 2018. "Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity" Antibodies 7, no. 1: 3.
https://doi.org/10.3390/antib7010003
APA Style
Dheilly, E., Majocchi, S., Moine, V., Didelot, G., Broyer, L., Calloud, S., Malinge, P., Chatel, L., Ferlin, W. G., Kosco-Vilbois, M. H., Fischer, N., & Masternak, K.
(2018). Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity. Antibodies, 7(1), 3.
https://doi.org/10.3390/antib7010003